Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinoma

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 6, 2012, Pages 503-512

  Liu, Zhen ^a,b   Chen, Jing ^b   Luo, Weiren ^b,c   Yang, Huiling ^c   Wu, Aibing ^b   Zhen, Yan ^b   Yu, Xiaoli ^b   Wang, Hao ^b   Yao, Kaitai ^b   Li, Xin ^b   Fang, Weiyi ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

DNA binding protein inhibitor 2; nasopharyngeal carcinoma; prognosis; proliferation

Indexed keywords

ID2 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 2; MESSENGER RNA; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; NASOPHARYNX; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PROGNOSIS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

GASTROPODA;

EID: 84861867006     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms030     Document Type: Article

References (37)

1. Cao SM, Simons MJ and Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011, 30:114-119.
2. Wang S and Fang W. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma. Histopathology 2011, 58:217-224.
3. Liu Z, Li X, He X, Jiang Q, Xie S, Yu X and Zhen Y, et al. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism. Int J Cancer 2011, 128:2562-2571.
4. Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y and Yi W, et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 2008, 123:2065-2072.
5. Fang WY, Liu TF, Xie WB, Yang XY, Wang S, Ren CP and Deng X, et al. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection. Acta Biochim Biophys Sin 2005, 37:541-546.
6. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L and Huang D, et al. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin 2009, 41:414-428.
7. Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, Zhu XF and Zeng YX, et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 2009, 125:1832-1841.
8. Coppe JP, Itahana Y, Moore DH, Bennington JL and Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 2004, 10:2044-2051.
9. Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D and Medeiros LJ, et al. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer 2008, 11:552-561.
10. Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen JJ, Zhao Y and Chao S, et al. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res 2006, 66:10870-10877.
11. Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, Bosch DA and Baas F, et al. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 2002, 38:329-338.
12. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P and Potten CS, et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 2001, 61:8803-8810.
13. Kleeff J, Ishiwata T, Friess H, Büchler MW, Israel MA and Korc M. The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res 1998, 58:3769-3772.
14. Perk J, Iavarone A and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 2005, 5:603-614.
15. Sikder HA, Devlin MK, Dunlap S, Ryu B and Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003, 3:525-530.
16. Meng Y, Gu C, Wu Z, Zhao Y, Si Y, Fu X and Han W. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors. BMC Cancer 2009, 9:75.
17. Lasorella A, Boldrini R, Dominici C, Donfrancesco A, Yokota Y, Inserra A and Iavarone A. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res 2002, 62:301-306.
18. Park HR, Jung WW, Kim HS, Santini-Araujo E, Kalil RK, Bacchini P and Bertoni F. Upregulation of the oncogenic helix-loop-helix protein Id2 in Ewing sarcoma. Tumori 2006, 9:236-240.
19. Rollin J, Bléchet C, Régina S, Tenenhaus A, Guyétant S and Gidrol X. The intracellular localization of ID2 expression has a predictive value in non small cell lung cancer. PLoS One 2009, 4:e4158.
20. Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM and Green AC, et al. Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. Int J Cancer 2006, 119:875-883.
21. Gray MJ, Dallas NA, Van Buren G, Xia L, Yang AD, Somcio RJ and Gaur P, et al. Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene 2008, 27:7192-7200.
22. Tsunedomi R, Iizuka N, Tamesa T, Sakamoto K, Hamaguchi T, Somura H and Yamada M, et al. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res 2008, 14:1025-1031.
23. Stighall M, Manetopoulos C, Axelson H and Landberg G. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells. Int J Cancer 2005, 115:403-411.
24. Agapova OA, Person E and Harbour JW. Id2 deficiency promotes metastasis in a mouse model of ocular cancer. Clin Exp Metastasis 2010, 27:91-96.
25. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S and Xie S, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008, 6:32.
26. Wu A, Wu B, Guo J, Luo W, Wu D, Yang H and Zhen Y, et al. Elevated expression of CDK4 in lung cancer. J Transl Med 2011, 9:38.
27. Chow LS, Lam CW, Chan SY, Tsao SW, To KF, Tong SF and Hung WK, et al. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Oncogene 2006, 25:310-316.
28. Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M and Cheng YJ, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 2006, 66:7999-8006.
29. Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T and Marubashi S, et al. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 2005, 26:319-327.
30. Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C and Ke Y. Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 2008, 14:2318-2325.
31. Kowanetz M, Valcourt U, Bergström R, Heldin CH and Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004, 24:4241-4254.
32. Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia L and Wu Y, et al. Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer 2010, 126:2102-2111.
33. Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T and Pfeifer A, et al. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med 2009, 206:221-232.
34. Zou J, Luo H, Zeng Q, Dong Z, Wu D and Liu L. Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes. J Transl Med 2011, 9:97.
35. Liu X and Feng R. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression. Acta Biochim Biophys Sin 2010, 42:496-501.
36. Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C and Rivard N. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. Int J Cancer 2009, 125:1575-1586.
37. Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S and Banerjee S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 2009, 124:36-45.